COVID-19 Genomics UK (COG-UK) Consortium: against COVID-19 Hub

COVID-19 Genomics UK (COG-UK) Consortium' is a collaboration between the NHS, Public Health England and other UK public health agencies, the Wellcome Sanger Institute, University of Cambridge and other academic institutions.

Project: COVID-19 Genomics UK (COG-UK) Consortium

Research Group: Cardiovascular Epidemiology Unit

Project Description: The COVID-19 Genomics UK (COG-UK) Consortium aims to increase the current capacity for SARS-CoV-2 genetic sequencing in the UK. This sequencing data will be used to understand the epidemiology and spread of the virus, and to monitor and evaluate interventions for COVID-19. SARS-CoV-2 genomic data will be integrated with NHS electronic health records and other existing genomic data to generate insights into susceptibility to COVID-19. From within the DPHPC, Professor John Danesh is a member of the COG-UK Steering Group, Dr Ewan Harrison will serve as the Scientific Project Manager and Dr Michael Chapman will lead the health informatics component.


Connections from

Technology: COVID Labs/Universities
Headquarters: United Kingdom
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: N/A
Industry: COVID R&D
Employee Number: N/A
Investor Type: N/A
Funding Status: N/A